MINI FUTURE LONG - MERCK & CO. | Real-time Euronext Paris 12:59:03 21/05/2024 BST | ||
| 2.904 EUR | -0.75% |
|
| Current month | +0.21% | ||
| 1 month | +17.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 21/05/24 | 2.904 | -0.75% |
| 20/05/24 | 2.926 | +2.52% |
| 17/05/24 | 2.854 | -1.31% |
| 16/05/24 | 2.892 | +1.80% |
| 15/05/24 | 2.841 | +7.17% |
Real-time Euronext Paris
Last update May 21, 2024 at 12:59 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| LK6NB | |
| ISIN | NLBNPNL2PNA1 |
| Date issued | 28/03/2024 |
| Strike | 99.68 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.265 € |
|---|---|
| Lowest since issue | 2.3 € |
| Spread | 0.102 € |
| Spread % | 3.44% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131
USD
Average target price
141.6
USD
Spread / Average Target
+8.13%
- Stock Market
- Certificates
- LK6NB Certificat
